Hyphens Pharma International Limited - Penyata Pendapatan (TTM)

Hyphens Pharma International Limited
$0.36 ↑0.02 (4.29%)
2025-09-11
HARGA SAHAM
Penyata Pendapatan (TTM)

Hyphens Pharma International Limited Penyata Pendapatan menunjukkan perubahan dalam pendapatan dan perbelanjaan sepanjang tempoh masa tertentu. Data Penyata Pendapatan termasuk Jualan dan Hasil, Untung Kasar, Penyelidikan dan Pembangunan (R&D), Jualan, Perbelanjaan Am dan Pentadbiran (SG&A), Pendapatan Operasi, Perbelanjaan Cukai Pendapatan, Perbelanjaan Faedah, Pendapatan Bukan Operasi, Perolehan sesaham (EPS), dan Saham Diterbitkan.

Semua nombor adalah kali 1,000,000 kecuali setiap unit saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Hasil 126 121 126 123 126 126 132 143 156 162 156 156 156 171 185 196 197 195 192 185
Perubahan (%) -3.84 4.19 -2.30 2.23 -0.01 4.86 8.17 9.54 3.78 -3.66 -0.04 0.04 9.09 8.65 5.49 0.55 -0.60 -1.65 -3.58
% daripada Hasil 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Kos jualan 83 79 83 78 80 78 82 89 96 100 96 97 99 110 120 128 127 127 125 119
Perubahan (%) -4.56 4.69 -6.37 3.11 -2.21 4.10 9.25 7.68 4.10 -4.02 1.01 2.30 10.44 9.54 6.66 -0.82 0.17 -1.67 -5.10
% daripada Hasil 66.12 65.63 65.94 63.20 63.74 62.34 61.89 62.51 61.45 61.63 61.40 62.04 63.44 64.23 64.75 65.47 64.58 65.08 65.06 64.04
Keuntungan Operasi Kasar 43 42 43 45 46 47 50 54 60 62 60 59 57 61 65 68 70 68 67 67
Perubahan (%) -2.44 3.23 5.57 0.72 3.86 6.12 6.41 12.64 3.28 -3.07 -1.70 -3.65 6.74 7.05 3.34 3.15 -2.00 -1.60 -0.76
% daripada Hasil 33.88 34.37 34.06 36.80 36.26 37.66 38.11 37.49 38.55 38.37 38.60 37.96 36.56 35.77 35.25 34.53 35.42 34.92 34.94 35.96
SG&A 36 37 37 39 37 40 40 43 40 48 48 48 48 50 50 52 50 55 69 57
Perubahan (%) 1.67 0.00 6.59 -6.18 8.07 0.00 9.00 -8.26 20.72 0.00 1.24 -1.23 4.57 -0.13 4.85 -4.63 9.92 25.24 -17.69
% daripada Hasil 28.66 30.30 29.09 31.73 29.12 31.47 30.01 30.25 25.33 29.47 30.58 30.98 30.58 29.32 26.95 26.79 25.41 28.10 35.78 30.54
R&D
Perubahan (%)
% daripada Hasil
OpEx 119 116 120 117 120 118 123 132 142 148 145 145 148 160 172 180 182 182 180 175
Perubahan (%) -2.68 3.21 -2.40 2.91 -1.84 3.86 7.98 7.37 4.00 -2.28 0.62 1.88 7.73 8.01 4.66 1.05 -0.11 -1.18 -2.59
% daripada Hasil 94.78 95.93 95.03 94.93 95.56 93.81 92.91 92.75 90.91 91.10 92.40 93.02 94.72 93.54 92.99 92.26 92.72 93.17 93.62 94.58
Pendapatan operasi 7 5 6 6 6 8 9 10 14 14 12 11 8 11 13 15 14 13 12 10
Perubahan (%) -25.00 27.32 -0.38 -10.43 39.30 20.07 10.63 37.34 1.65 -17.77 -8.09 -24.41 33.44 18.00 16.50 -5.46 -6.83 -8.01 -18.11
% daripada Hasil 5.22 4.07 4.97 5.07 4.44 6.19 7.09 7.25 9.09 8.90 7.60 6.98 5.28 6.46 7.01 7.74 7.28 6.83 6.38 5.42
Perbelanjaan Faedah -0 -0 -0 -0 -0 -0 -0 -0 -0 -0 -0 -0 -0 -0 -0 -0 -0 -1 -1 -1
Perubahan (%) 0.92 -0.00 -2.73 2.80 -13.64 -0.00 18.95 -15.93 150.53 -0.00 37.39 -27.22 16.81 -0.00 15.83 -13.66 103.24 26.46 -6.93
% daripada Hasil -0.09 -0.09 -0.09 -0.09 -0.09 -0.08 -0.07 -0.08 -0.06 -0.15 -0.15 -0.21 -0.15 -0.16 -0.15 -0.16 -0.14 -0.29 -0.37 -0.36
Pendapatan bersih 7 6 6 6 6 7 8 9 12 11 10 9 7 9 10 10 10 10 8 6
Perubahan (%) -9.29 0.19 0.34 3.92 6.32 15.51 9.93 34.90 -3.21 -16.03 -8.13 -23.18 27.37 15.71 5.06 -0.03 -2.10 -18.48 -22.26
% daripada Hasil 5.40 5.09 4.90 5.03 5.11 5.44 5.99 6.09 7.50 6.99 6.10 5.60 4.30 5.02 5.35 5.33 5.30 5.22 4.32 3.49

Source: Capital IQ

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista